Failure of prophylactic zinc in Wilson disease.

Simple item page
dc.contributor.authorMishra, Devendraen_US
dc.contributor.authorKalra, Veenaen_US
dc.contributor.authorSeth, Rachnaen_US
dc.date.accessioned2008-02-04en_US
dc.date.accessioned2009-05-27T05:25:31Z
dc.date.available2008-02-04en_US
dc.date.available2009-05-27T05:25:31Z
dc.date.issued2008-02-04en_US
dc.description.abstractEarly institution of prophylactic therapy of asymptomatic Wilson disease patients can prevent the expression of the disease. Zinc is currently preferred therapy for presymptomatic patients. We report onset of symptomatic disease in a presymptomatic patient and deterioration of biochemical parameters in another, despite appropriate zinc therapy.en_US
dc.description.affiliationChild Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110 029, India.en_US
dc.identifier.citationMishra D, Kalra V, Seth R. Failure of prophylactic zinc in Wilson disease. Indian Pediatrics. 2008 Feb; 45(2): 151-3en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/10757
dc.language.isoengen_US
dc.source.urihttps://indianpediatrics.neten_US
dc.subject.meshBrain --pathologyen_US
dc.subject.meshChilden_US
dc.subject.meshHepatolenticular Degeneration --diagnosisen_US
dc.subject.meshHumansen_US
dc.subject.meshMagnetic Resonance Imagingen_US
dc.subject.meshMaleen_US
dc.subject.meshTreatment Failureen_US
dc.subject.meshZinc --therapeutic useen_US
dc.titleFailure of prophylactic zinc in Wilson disease.en_US
dc.typeCase Reportsen_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Pediatrics